Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Cancer Research|March 7, 2015
CDK4/6 Inhibitor PD 0332991 Sensitizes Acute Myeloid Leukemia to Cytarabine-Mediated CytotoxicityChenyi Yang, Cynthia A Boyson, Maurizio Di Liberto, et al.Proceedings of the National Academy of Sciences of the United States of America|December 14, 2004
Homeostatic cell-cycle control by BLyS: Induction of cell-cycle entry but not G1/S transition in opposition to p18INK4c and p27Kip1Xiangao Huang, Maurizio Di Liberto, Adam F Cunningham, et al.Journal of Medicinal Chemistry|May 2, 2026
Intracellular Activation of Dual-Pharmacophore Artezomib Enhances Selective Cytotoxicity in Hematologic MalignanciesDaqiang Li, Xiangao Huang, Zoe Chow, et al.Blood|January 30, 2019
A phase 1 trial of ibrutinib plus palbociclib in previously treated mantle cell lymphomaPeter Martin, Nancy L Bartlett, Kristie A Blum, et al.Blood|June 22, 2012
Prolonged early G(1) arrest by selective CDK4/CDK6 inhibition sensitizes myeloma cells to cytotoxic killing through cell cycle-coupled loss of IRF4Xiangao Huang, Maurizio Di Liberto, David Jayabalan, et al.Biorxiv : the Preprint Server for Biology|September 15, 2025
Leveraging BRG1 Driven Ferroptosis Resistance to Overcome Treatment ResistanceSoo-Yeon Hwang, Helgi Nikolli, Belem Yoval-Sánchez, et al.Cancer Discovery|August 2, 2014
Cell-cycle reprogramming for PI3K inhibition overrides a relapse-specific C481S BTK mutation revealed by longitudinal functional genomics in mantle cell lymphomaDavid Chiron, Maurizio Di Liberto, Peter Martin, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 2011
MAGE-A inhibits apoptosis in proliferating myeloma cells through repression of Bax and maintenance of survivinTricia Nardiello, Achim A Jungbluth, Anna Mei, et al.Nature Communications|March 29, 2023
Histone demethylase KDM2A is a selective vulnerability of cancers relying on alternative telomere maintenanceFei Li, Yizhe Wang, Inah Hwang, et al.Biorxiv : the Preprint Server for Biology|February 17, 2023
Histone demethylase KDM2A is a selective vulnerability of cancers relying on alternative telomere maintenanceFei Li, Yizhe Wang, Inah Hwang, et al.Pageof 3